| Wellspan Pharmacy | |
| 25 Monument Rd, Ste 265, York, Pennsylvania 17403 | |
| (717) 741-8150 |
| Name | Wellspan Pharmacy |
|---|---|
| Organization Name | Wellspan Pharmacy Inc |
| Location | 25 Monument Rd, Ste 265, York, Pennsylvania 17403 |
| Type | Supplier |
| Phone | (717) 741-8150 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
"Cooperation is essential to combat diseases that cross national borders," Ramanan Laxminarayan, director of the Center for Disease Dynamics, Economics and Policy and a research scholar and lecturer at Princeton University, and Bryan Grenfell and Petra Klepac of Princeton University write in a SciDev.Net opinion piece.
Tibotec Pharmaceuticals today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for TMC278 (rilpivirine), an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), being studied for once-daily use with other antiretroviral agents in treatment-naive HIV-1-infected adults. If approved, TMC278 will be the third anti-HIV compound to be introduced by Tibotec Pharmaceuticals.
Only about 6 in 10 lung cancer patients in the United States receive the minimal lung cancer treatments recommended by the National Comprehensive Cancer Network guidelines, according to new research published online in the Annals of the American Thoracic Society.
In a widely noticed study, developmental psychologists reported that 14-month-old infants imitate an unusual action if it was chosen deliberately by the person they observed, but not if it could be attributed to external constraints. This selective imitation was put forth as evidence for an early understanding of rational action and action goals.
Synta Pharmaceuticals Corp. today presented results at the Annual Meeting of the American Society for Clinical Oncology (ASCO) from a Phase 2 single agent clinical trial of ganetespib in gastrointestinal stromal tumors (GIST) and a Phase 1 trial of ganetespib in solid tumors evaluating a twice-weekly administration schedule.
› Verified 7 days ago
News Archive
"Cooperation is essential to combat diseases that cross national borders," Ramanan Laxminarayan, director of the Center for Disease Dynamics, Economics and Policy and a research scholar and lecturer at Princeton University, and Bryan Grenfell and Petra Klepac of Princeton University write in a SciDev.Net opinion piece.
Tibotec Pharmaceuticals today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for TMC278 (rilpivirine), an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), being studied for once-daily use with other antiretroviral agents in treatment-naive HIV-1-infected adults. If approved, TMC278 will be the third anti-HIV compound to be introduced by Tibotec Pharmaceuticals.
Only about 6 in 10 lung cancer patients in the United States receive the minimal lung cancer treatments recommended by the National Comprehensive Cancer Network guidelines, according to new research published online in the Annals of the American Thoracic Society.
In a widely noticed study, developmental psychologists reported that 14-month-old infants imitate an unusual action if it was chosen deliberately by the person they observed, but not if it could be attributed to external constraints. This selective imitation was put forth as evidence for an early understanding of rational action and action goals.
Synta Pharmaceuticals Corp. today presented results at the Annual Meeting of the American Society for Clinical Oncology (ASCO) from a Phase 2 single agent clinical trial of ganetespib in gastrointestinal stromal tumors (GIST) and a Phase 1 trial of ganetespib in solid tumors evaluating a twice-weekly administration schedule.
› Verified 7 days ago
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2350 Freedom Way, York, Pennsylvania 17402 Phone: (717) 741-3222 | |
Cvs Pharmacy #01657 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2080 S Queen St, York, Pennsylvania 17403 Phone: (717) 845-1633 | |
Cvs Pharmacy #07677 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 165s Richland Ave, York, Pennsylvania 17404 Phone: (717) 843-4730 | |
Cvs Pharmacy #04215 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 820 Edgewood Rd, York, Pennsylvania 17402 Phone: (717) 757-6252 | |
Lincare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2350 Freedom Way, York, Pennsylvania 17402 Phone: (717) 741-6682 |